Paul Capital Royalty Acquisition Fund

Paul Capital Royalty Acquisition Fund was a specialized investment vehicle managed by Paul Capital that pioneered the acquisition of royalty interests in the healthcare sector. The fund provided non-dilutive financing to biotechnology companies, academic institutions, and inventors by purchasing future royalty streams from approved or late-stage pharmaceutical products and medical devices. In 2006, the healthcare royalty team transitioned out of Paul Capital to establish HealthCare Royalty Partners (HCRP), an independent firm that continues this investment strategy. During its operation, the fund built a diverse portfolio of royalty interests in numerous blockbuster therapies across multiple therapeutic categories.